Four years after Russia launched its full-scale invasion, Ukraine faces a growing mental health crisis. Some with severe PTSD ...
Universities connect talent, industry and healthcare to accelerate healthtech innovation, turning research into real-world impact while tackling barriers.
Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.
Investigator-sponsored trial backed by Glaucoma UK and HSC R&D Division targets rapidly growing patient population; first enrollment expected Q2 2026 ...
Sheffield Children’s NHS Foundation Trust has become the first site in Europe to recruit a patient to a major international clinical trial investigating a potential new treatment for a severe form of ...
Listerine explores whether brushing and flossing are sufficient for maintaining oral health and the adjunctive therapies that ...
The British Pharmacological Society (BPS) said that women are often left making decisions about taking medicines without clear evidence when they are pregnant or breastfeeding. And the information ...
DYNAMIKA™ delivers SOC 2 Type II–certified, AI‑driven imaging workflows, giving pharma and biotech secure, compliant ...
The British Pharmacological Society has called for clearer, evidence-based guidance on medication use during pregnancy and breastfeeding ...
The UK will spend more than £1 billion ($1.3 billion) on quantum computing research over the next four years, as governments boost investment into a technology that’s increasingly considered critical ...
Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.
Introduction Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results